Nasdaq: $29.19 (-0.44) | AIM: £4.04 (-0.34)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Major Shareholders
Financial Reports
SEC Filings
Share Price & Chart
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
AIM Rule 26
Careers
About Us
Overview
Corporate Information
Board of Directors
Senior Management
Contact Us
What We Do
Overview
Research and Development
Commercialization
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Presentations
Recent News
All RNS & Press Releases
Presentations & Publications
Mailing List Sign-up
Shareholder Information
Overview
Events, Circulars & Forms
Major Shareholders
Financial Reports
SEC Filings
Share Price & Chart
Analyst Coverage
Dual-listing FAQs
Information for Shareholders
Warning to Shareholders
Terms of Reference & Policies
Audit Committee – Terms of Reference
AIM Rule 26
Careers
Terms of Reference & Policies
Hutchmed
Shareholder Information
| Terms of Reference & Policies
Audit Committee - Terms of Reference
Nomination Committee - Terms of Reference
Remuneration Committee - Terms of Reference
Technical Committee - Terms of Reference
Board Diversity Policy
Code of Ethics
Code of Ethics – Business Partners
Tax Strategy
Director Nomination Policy
Complaints Procedures
Information Security Policy
Confidential & Price-Sensitive Insider Information and Securities Dealing Policies
Statement of Compliance with the UK Corporate Governance Code